Artificial pancreas could help type 2 diabetics

The UK’s National Health Service (NHS) may soon implement a new device that could change the lives of thousands of people.

reason? Wellness centers may offer a technology that automatically manages sugar in people with type 1 diabetes. More than 100,000 people are expected to benefit, according to the BBC.

But that’s not all. Some scientists have recently discovered that the device, known as an artificial pancreas, May also be effective in people with type 2 diabetes,

Type 2 diabetes is the most common form of the disease, affecting approximately 415 million people worldwide.

On the other hand, 90% of England’s 4 million diabetics have type 2 diabetes, according to Diabetes UK.

Within the framework of the University of Cambridge survey, Experts were able to demonstrate that the device insulin to improve glycemic control in “closed-loop” patients“No increase in hypoglycemia compared with standard insulin therapy,” the study states.

This may be a safer and more effective way to improve type 2 diabetes control in these patients.

In this disease, standard therapy is that patients must inject insulin every day. However, this approach may leave unwanted side effects such as pain, nerve damage and risk of amputation.

“Many people with type 2 diabetes struggle to control blood sugar levels with current treatments”said lead author Charlotte Bowden of the study.

In this regard, he added, “an artificial pancreas may offer a safe and effective way to help them, and the technology is easy to use and can be safely implemented at home.”

The “closed loop” system works as follows: Using one sensor and one insulin pump application developed by research teamIt should be kept in the patient’s body to control blood sugar levels.

The app uses an algorithm to predict how much insulin a person will need to achieve healthy blood sugar levels.

For the study, the University of Cambridge interviewed 26 patients. Half of the group tested the device, while the other half stuck to their usual regimen of insulin injections.

found during testing Those who tried the automated device were within their blood sugar goals 66 percent of the time.Compared with 32% of patients who received standard care.

The investigation found that no patients experienced extremely low blood sugar (hypoglycemia) during the trial.

In addition, reflect Participants report that they are satisfied with devices that can automatically monitor blood sugar levelsin fact, nearly 89 percent admitted to spending less time than usual dealing with their type 2 diabetes.